Lisa Kuhns, PhD, MD

News
Machine Learning Advances Revolutionize Pulmonary Arterial Hypertension Diagnosis
12/09/2024
Machine learning techniques such as combining machine learning with echocardiography and electrocardiography (ECG), show promising results in diagnosing pulmonary arterial hypertension (PAH), offering a potential noninvasive alternative to...
Machine learning techniques such as combining machine learning with echocardiography and electrocardiography (ECG), show promising results in diagnosing pulmonary arterial hypertension (PAH), offering a potential noninvasive alternative to...
Machine learning techniques such...
12/09/2024
First Report Managed Care
News
Enhanced AI Model Outperforms Traditional Techniques in Endometrial Cancer Diagnosis
12/06/2024
A cutting-edge artificial intelligence (AI) model significantly improves the accuracy and efficiency of diagnosing high-risk endometrial cancer (EC) and predicting postoperative recurrence compared to traditional methods.
A cutting-edge artificial intelligence (AI) model significantly improves the accuracy and efficiency of diagnosing high-risk endometrial cancer (EC) and predicting postoperative recurrence compared to traditional methods.
A cutting-edge artificial...
12/06/2024
Journal of Clinical Pathways
News
Family History and Genetic Risk Shape Parkinson Disease Progression
12/06/2024
Patients with Parkinson disease (PD) and with a family history of the condition may experience slower disease progression and a lower risk of developing freezing of gait.
Patients with Parkinson disease (PD) and with a family history of the condition may experience slower disease progression and a lower risk of developing freezing of gait.
Patients with Parkinson disease...
12/06/2024
Annals of Long-Term Care
News
Respiratory Syncytial Virus Subgroups A and B Contribute Equally to the Global RSV Burden, Study Finds
12/06/2024
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus...
12/06/2024
Pharmacy Learning Network
News
Frequent COVID-19 Booster Vaccination Reduces Severe Disease Risk Across Key Groups
12/05/2024
Frequent COVID-19 booster vaccinations significantly lower the risk of severe disease, particularly in older adults and immunocompromised individuals.
Frequent COVID-19 booster vaccinations significantly lower the risk of severe disease, particularly in older adults and immunocompromised individuals.
Frequent COVID-19 booster...
12/05/2024
Integrated Healthcare Executive
News
Study Highlights Safety and Effectiveness of Pulsed Field Ablation for Treating Atrial Fibrillation
12/04/2024
Pulsed Field Ablation (PFA) demonstrates promising safety and efficacy in real-world clinical practice in treating atrial fibrillation, according to a study published in Nature Medicine.
Pulsed Field Ablation (PFA) demonstrates promising safety and efficacy in real-world clinical practice in treating atrial fibrillation, according to a study published in Nature Medicine.
Pulsed Field Ablation (PFA)...
12/04/2024
Annals of Long-Term Care
News
Antilymphocyte Globulin Improves Outcomes in Patients With Myelofibrosis Undergoing Stem Cell Transplantation
11/22/2024
Using antithymocyte/antilymphocyte globulin (ATLG) in patients with myelofibrosis undergoing allogeneic hematopoietic stem cell transplantation (alloHCT) may improve graft-versus-host disease-free and relapse-free survival (GRFS) rates.
Using antithymocyte/antilymphocyte globulin (ATLG) in patients with myelofibrosis undergoing allogeneic hematopoietic stem cell transplantation (alloHCT) may improve graft-versus-host disease-free and relapse-free survival (GRFS) rates.
Using...
11/22/2024
Journal of Clinical Pathways
News
Emicizumab as a Potential Treatment Pathway for Select Hemophilia B Cases
11/22/2024
New research highlights the potential of emicizumab, traditionally used to treat hemophilia A (HA), as a promising alternative therapy for certain hemophilia B (HB) genotypes.
New research highlights the potential of emicizumab, traditionally used to treat hemophilia A (HA), as a promising alternative therapy for certain hemophilia B (HB) genotypes.
New research highlights the...
11/22/2024
First Report Managed Care
News
Patisiran Shows Promise in Treating Hereditary Transthyretin Amyloidosis With Polyneuropathy
11/22/2024
Patisiran offers promising benefits for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN), a rare and fatal genetic disorder characterized by amyloid fibril deposits affecting multiple organs.
Patisiran offers promising benefits for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN), a rare and fatal genetic disorder characterized by amyloid fibril deposits affecting multiple organs.
Patisiran offers promising...
11/22/2024
First Report Managed Care
News
Thrombosis and Inflammation Drive Mortality and Cancer Risk in Myeloproliferative Disorders
11/15/2024
Despite the advancements in treatment, thrombosis remains a significant challenge for patients with myeloproliferative neoplasms (MPNs), leading to increased mortality and the development of secondary cancers.
Despite the advancements in treatment, thrombosis remains a significant challenge for patients with myeloproliferative neoplasms (MPNs), leading to increased mortality and the development of secondary cancers.
Despite the advancements in...
11/15/2024
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use